Objective and background. The objective of the deliverable at hand is to analyse the work performed and results achieved in WP2 and WP3 as of 2020-07-13. The objective is to identify key challenges, key opportunities and derive concrete key actions and implementation paths to xxxxxx the open science code of conduct in the European AAT community. By analysing the work and results of WP2 and WP3, we can align the OSCAR project more precisely with its main goal that is to show how open science can be integrated into European AAT research projects in the future. The deliverable D4.1 is an important step for the ongoing project process particularly for the development of the pilot version of the open science code of conduct (D4.3) as well as for the planned simulated integration of the code of conduct into selected European pilot projects (WP5).
Objective and background. A. Objective 1 B. Background 2
Objective and background. One of the main goals of work package 4 (WP4) is to develop an open science code of conduct for the European AAT research landscape. For this purpose, preparatory work had and has to be done to explore and define the appropriate content and structure of the open science code of conduct. Furthermore, it is important to have a concise and comprehensive roadmap that lays out all the necessary steps, activities and milestones. Based on our early planning at the beginning of the OSCAR project and based on insights form deliverable D4.1 we were able to develop such a roadmap. The key elements of this roadmap to our code of conduct are presented in the deliverables D4.2 at hand.
Objective and background. The objective of this agreement (“Agreement”) is to regulate the Parties’ rights and obligations regarding the processing of personal and health data in accordance with Norwegian law and the EU General Data Protection Regulation (“GDPR”), confer personopplysningsloven (Act on Processing of Personal Data of the 15th of June 2018 number 38) § 1 in conjunction with Article 28 number 3 of the GDPR. The Agreement shall ensure that no personal data is to be processed inappropriately or unlawfully and that confidentiality, integrity, availability, and resilience of the data is maintained during the assignment. The Agreement regulates the Processor’s processing activities on behalf of the Controller, hereunder among other activities collection, recording, structuring, storage, adaptation, alteration, retrieval, disclosure, erasure, and restriction of personal data, or any combinations of these. The main objective of the Processor’s processing of personal data on behalf of the Controller is to assist the Controller in complying with the Controller‘s legal obligation to report adverse events or reactions during clinical trials to the applicable supervisory agencies. Personal data processed on behalf of the Processor may not be used for purposes other than the delivery and management of information regarding reporting of adverse events or reactions without the Controller’s prior approval. The Processor shall not transfer personal data covered by this Agreement to anyone other than the Controller, except in accordance with this Agreement or a subsequent agreement between the Parties.
Objective and background. The objective of this Agreement is to regulate the processing of personal data which the Processor is performing on behalf of the Controller. The Agreement regulates the Parties’ compliance with the Personal Data Protection Act and the General Data Protection Regulation with regard to the processing of personal data performed by the Processor on behalf of the Controller. The Agreement imposes upon the Parties all the rights and obligations required to comply with the Personal Data Protection Act and the General Data Protection Regulation. This Agreement is an integral part of the Processor’s Standard Conditions. The Agreement shall apply to the Parties when they are bound by the Processor’s Standard Conditions. The Processor may amend and update this Agreement unilaterally if all amendments and updates ensure compliance with current personal data protection legislation, including the Personal Data Protection Act, the General Data Protection Regulation and any subsequent personal data protection legislation. The Processor shall inform the Controller of any such changes. The purpose of the processing regulated by this Agreement is to provide access to and operation of the agreed services/products covered by the Standard Conditions. The Processor shall process the following types of personal data on behalf of the Controller: Location details for vehicles (GPS coordinates) and information deriving therefrom • Identification details for employees (names, ID numbers, allocated vehicles, contact details etc.) • Contact details (names, e-mails, addresses, telephone numbers etc. of persons/customers) • Registration details for vehicles • With regard to HealthCare: Location, identification and contact details for persons carrying monitored equipment [...] The Processor is assigned to process personal data within the following categories of data subjects: • Employees • Tenants and other customers, including children • Service providers The Processor has designed his systems so as – in principle – not to process sensitive data on behalf of the Controller.
Objective and background. The objective of this agreement (“Agreement”) is to regulate the Parties’ rights and obligations regarding the processing of personal and health data in accordance with Norwegian law and the EU General Data Protection Regulation (“GDPR”), confer Act on Processing of Personal Data of the 15th of June 2018 number 38 § 1 in conjunction with Article 28 number 3 of the GDPR. The Agreement shall ensure that no personal data is to be processed inappropriately or unlawfully and that confidentiality, integrity, availability, and resilience of the data is maintained during the assignment. The Agreement regulates the Processor’s processing activities on behalf of the Controller, hereunder among other activities collection, recording, structuring, storage, adaptation, alteration, retrieval, disclosure, erasure, and restriction of personal data, or any combinations of these. The main objective of the Processor’s processing of personal data on behalf of the Controller is to assist the Controller in complying with the Controller‘s obligation to monitor the clinical trial NAME OF STUDY. Personal data processed on behalf of the Processor may not be used for purposes other than the delivery and management of information in connection to the performance of monitoring services without the Controller’s prior written approval. The Processor shall not transfer personal data covered by this Agreement to anyone other than the Controller, except in accordance with this Agreement or a subsequent agreement between the Parties.
Objective and background. 1.1. The objective of this agreement (“Agreement”) is to regulate the Parties’ rights and obligations regarding the clinical trial “NAME” under protocol PROTOCOL (“Trial”). Trial documentation provided from Sponsor to Company contains a complete description of the proposed trial, including, without limitation, the research objectives, methods, procedures, costs and timelines, available at the time of the proposal. Sponsor shall keep Company updated with any changes or modifications to the Trial documentation. The Trial has received the necessary regulatory and ethical approvals to initiate. The Trial has the following EU CT/EUDAMED/case number: XXX. 1.2. The Trial is to be carried out by Sponsor with support by Company. Sponsor is responsible ensures it has the appropriate facilities and personnel necessary to conduct the Trial and that participating clinical sites (“Centres”) will have the appropriate facilities and personnel necessary to conduct the Trial. NAME, acting as Coordinating Investigator (“Coordinating Investigator”), will be coordinating the Trial for Sponsor. 1.3. Sponsor and Centres, including Coordinating Investigator and Centres’ Principal Investigators are responsible for providing medical care and to ensure the well-being of the Trial participants (“Trial Subjects”) throughout the Trial. 1.1 Choose EU CT or EUDAMED no, according to the type of trial.
Objective and background
